{
 "generated": "2026-11-03T15:37:36.214689Z",
 "since": "2026-11-01",
 "n": 141,
 "items": [
  {
   "id": "NCT06303505",
   "kind": "changed",
   "title": "FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC",
   "sponsor": "Gilead Sciences",
   "phase": "P1/P2",
   "pcd": "2027-12",
   "what": [
    "enrollment: 250 \u2192 334",
    "primary outcome text: Phase 1: Percentage of Participants Experiencing any Dose-limiting Toxicities (DLTs)[ \u2192 Phase 1: Percentage of Participants Experiencing any Dose-limiting Toxicities (DLTs)"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06303505",
   "registry": "https://clinicaltrials.gov/study/NCT06303505"
  },
  {
   "id": "NCT05327114",
   "kind": "changed",
   "title": "Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)",
   "sponsor": "Janssen Research & Development, LLC",
   "phase": "P2/P3",
   "pcd": "2026-12-15",
   "what": [
    "primary completion: 2027-05-14 \u2192 2026-12-15"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT05327114",
   "registry": "https://clinicaltrials.gov/study/NCT05327114"
  },
  {
   "id": "NCT06618001",
   "kind": "status",
   "title": "A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms",
   "sponsor": "Janssen Research & Development, LLC",
   "phase": "P1",
   "pcd": "2026-09-01",
   "what": [
    "primary completion: 2026-09-02 \u2192 2026-09-01",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06618001",
   "registry": "https://clinicaltrials.gov/study/NCT06618001"
  },
  {
   "id": "NCT07157254",
   "kind": "new",
   "title": "A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)",
   "sponsor": "Ultragenyx Pharmaceutical Inc",
   "phase": "P2",
   "pcd": "2026-10-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07157254",
   "registry": "https://clinicaltrials.gov/study/NCT07157254"
  },
  {
   "id": "NCT07913347",
   "kind": "new",
   "title": "Safety, Dosage, and Microbiome Engraftment Study of MGT-006 for Ulcerative Colitis (ROOT Study)",
   "sponsor": "Metagen Therapeutics, Inc.",
   "phase": "P1/P2",
   "pcd": "2028-03-31",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913347",
   "registry": "https://clinicaltrials.gov/study/NCT07913347"
  },
  {
   "id": "NCT07912827",
   "kind": "new",
   "title": "Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects",
   "sponsor": "Yuhan Corporation",
   "phase": "P1",
   "pcd": "2027-02-02",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07912827",
   "registry": "https://clinicaltrials.gov/study/NCT07912827"
  },
  {
   "id": "NCT07059767",
   "kind": "firmed",
   "title": "Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge",
   "sponsor": "Ethris GmbH",
   "phase": "P2",
   "pcd": "2026-09-01",
   "what": [
    "primary completion: 2026-06 \u2192 2026-09-01",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07059767",
   "registry": "https://clinicaltrials.gov/study/NCT07059767"
  },
  {
   "id": "NCT07851649",
   "kind": "status",
   "title": "A Study to Assess the Bioavailability and Adhesion of Estradiol/Levonorgestrel TDS in Healthy Post-Menopausal Female Participants",
   "sponsor": "Corium Innovations, Inc.",
   "phase": "P1",
   "pcd": "2026-09-29",
   "what": [
    "primary completion: 2026-09-08 \u2192 2026-09-29",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07851649",
   "registry": "https://clinicaltrials.gov/study/NCT07851649"
  },
  {
   "id": "NCT07913061",
   "kind": "new",
   "title": "A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin",
   "sponsor": "Jiangsu HengRui Medicine Co., Ltd.",
   "phase": "P3",
   "pcd": "2028-01",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913061",
   "registry": "https://clinicaltrials.gov/study/NCT07913061"
  },
  {
   "id": "NCT07827573",
   "kind": "status",
   "title": "A Study to Learn How Well Participants With a Specific Type of Early Breast Cancer (ER-Positive, HER2-Negative) Tolerate and Stay on Treatment With Giredestrant",
   "sponsor": "Hoffmann-La Roche",
   "phase": "P3",
   "pcd": "2028-11-30",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07827573",
   "registry": "https://clinicaltrials.gov/study/NCT07827573"
  },
  {
   "id": "NCT07856082",
   "kind": "status",
   "title": "Opt-IVF for Personalized Medicine for Normal Responders",
   "sponsor": "Urmila DIwekar",
   "phase": "P1/P2",
   "pcd": "2027-03-31",
   "what": [
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07856082",
   "registry": "https://clinicaltrials.gov/study/NCT07856082"
  },
  {
   "id": "NCT07911748",
   "kind": "new",
   "title": "A Study of MBS314 for Injectionin Participants With Relapsed/Refractory Multiple Myeloma.",
   "sponsor": "Beijing Mabworks Biotech Co., Ltd.",
   "phase": "P1/P2",
   "pcd": "2027-12",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07911748",
   "registry": "https://clinicaltrials.gov/study/NCT07911748"
  },
  {
   "id": "NCT05773820",
   "kind": "slipped",
   "title": "A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors",
   "sponsor": "Wigen Biomedicine Technology (Shanghai) Co., Ltd.",
   "phase": "P1/P2",
   "pcd": "2027-12-31",
   "what": [
    "primary completion: 2026-08-08 \u2192 2027-12-31",
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 210 \u2192 63"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT05773820",
   "registry": "https://clinicaltrials.gov/study/NCT05773820"
  },
  {
   "id": "NCT02494986",
   "kind": "firmed",
   "title": "A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies",
   "sponsor": "Janssen Sciences Ireland UC",
   "phase": "P2",
   "pcd": "2026-08-18",
   "what": [
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT02494986",
   "registry": "https://clinicaltrials.gov/study/NCT02494986"
  },
  {
   "id": "NCT06903338",
   "kind": "firmed",
   "title": "A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection",
   "sponsor": "Vir Biotechnology, Inc.",
   "phase": "P3",
   "pcd": "2026-09-30",
   "what": [
    "primary completion: 2026-12-31 \u2192 2026-09-30",
    "date type: ESTIMATED \u2192 ACTUAL"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06903338",
   "registry": "https://clinicaltrials.gov/study/NCT06903338"
  },
  {
   "id": "NCT07773129",
   "kind": "firmed",
   "title": "A Study to Learn How ASP3082 is Processed in Healthy Men",
   "sponsor": "Astellas Pharma Global Development, Inc.",
   "phase": "P1",
   "pcd": "2026-10-20",
   "what": [
    "primary completion: 2026-10-31 \u2192 2026-10-20",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07773129",
   "registry": "https://clinicaltrials.gov/study/NCT07773129"
  },
  {
   "id": "NCT07913360",
   "kind": "new",
   "title": "GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal Cancer",
   "sponsor": "Genfleet Therapeutics (Shanghai) Inc.",
   "phase": "P3",
   "pcd": "2028-11",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913360",
   "registry": "https://clinicaltrials.gov/study/NCT07913360"
  },
  {
   "id": "NCT07911683",
   "kind": "new",
   "title": "Study Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular Carcinoma",
   "sponsor": "BeOne Medicines",
   "phase": "P2",
   "pcd": "2028-03-31",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07911683",
   "registry": "https://clinicaltrials.gov/study/NCT07911683"
  },
  {
   "id": "NCT07903493",
   "kind": "status",
   "title": "Phase Ia Study of MST-931 in Healthy Adult Subjects",
   "sponsor": "Mabsoft Therapeutics (Shanghai) Co., Ltd.",
   "phase": "P1",
   "pcd": "2027-07-30",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07903493",
   "registry": "https://clinicaltrials.gov/study/NCT07903493"
  },
  {
   "id": "NCT07224360",
   "kind": "slipped",
   "title": "Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)",
   "sponsor": "CSL Behring",
   "phase": "P2",
   "pcd": "2028-08-15",
   "what": [
    "primary completion: 2028-06-29 \u2192 2028-08-15"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07224360",
   "registry": "https://clinicaltrials.gov/study/NCT07224360"
  },
  {
   "id": "NCT07913763",
   "kind": "new",
   "title": "Rimonabant for Improving Walking Ability in Patients With Chronic Stroke",
   "sponsor": "Sinfatin S.L",
   "phase": "P2",
   "pcd": "2028-01-31",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913763",
   "registry": "https://clinicaltrials.gov/study/NCT07913763"
  },
  {
   "id": "NCT07685600",
   "kind": "firmed",
   "title": "Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants",
   "sponsor": "AstraZeneca",
   "phase": "P1",
   "pcd": "2026-10-22",
   "what": [
    "primary completion: 2026-10-28 \u2192 2026-10-22",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07685600",
   "registry": "https://clinicaltrials.gov/study/NCT07685600"
  },
  {
   "id": "NCT07912593",
   "kind": "new",
   "title": "Phase 1/2, Open-label Study of ETX-929, a KRAS Inhibitor in Participants With Advanced Solid Tumors",
   "sponsor": "Ensem Therapeutics",
   "phase": "P1/P2",
   "pcd": "2028-10-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07912593",
   "registry": "https://clinicaltrials.gov/study/NCT07912593"
  },
  {
   "id": "NCT07911579",
   "kind": "new",
   "title": "A Study of SYH2051 in Combination With Irinotecan Hydrochloride Liposome Injection in Subjects With Advanced Solid Tumors",
   "sponsor": "CSPC ZhongQi Pharmaceutical Technology Co., Ltd.",
   "phase": "P1/P2",
   "pcd": "2028-12-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07911579",
   "registry": "https://clinicaltrials.gov/study/NCT07911579"
  },
  {
   "id": "NCT07753850",
   "kind": "status",
   "title": "A Study of SL-325 in Crohn's Disease Patients",
   "sponsor": "Shattuck Labs, Inc.",
   "phase": "P2",
   "pcd": "2028-07",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07753850",
   "registry": "https://clinicaltrials.gov/study/NCT07753850"
  },
  {
   "id": "NCT07911735",
   "kind": "new",
   "title": "A Phase \u2161 Clinical Trial Evaluating the Efficacy and Safety of SYH2072 Tablets In Hypertensive Patients",
   "sponsor": "InnovStone Therapeutics Limited",
   "phase": "P2",
   "pcd": "2027-07-22",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07911735",
   "registry": "https://clinicaltrials.gov/study/NCT07911735"
  },
  {
   "id": "NCT07898800",
   "kind": "status",
   "title": "Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen Allergy",
   "sponsor": "Desentum Oy",
   "phase": "P1",
   "pcd": "2027-03",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07898800",
   "registry": "https://clinicaltrials.gov/study/NCT07898800"
  },
  {
   "id": "NCT05805501",
   "kind": "firmed",
   "title": "A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinom",
   "sponsor": "Hoffmann-La Roche",
   "phase": "P2",
   "pcd": "2026-10-05",
   "what": [
    "primary completion: 2026-10-08 \u2192 2026-10-05",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT05805501",
   "registry": "https://clinicaltrials.gov/study/NCT05805501"
  },
  {
   "id": "NCT07906717",
   "kind": "status",
   "title": "A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer",
   "sponsor": "Janssen Research & Development, LLC",
   "phase": "P3",
   "pcd": "2028-02-14",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07906717",
   "registry": "https://clinicaltrials.gov/study/NCT07906717"
  },
  {
   "id": "NCT07913282",
   "kind": "new",
   "title": "ARTEMIS: UC-MSCs After Mechanical Thrombectomy for Acute Ischemic Stroke",
   "sponsor": "Royan Stem Cell Technology Company",
   "phase": "P1",
   "pcd": "2027-11-20",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913282",
   "registry": "https://clinicaltrials.gov/study/NCT07913282"
  },
  {
   "id": "NCT07196748",
   "kind": "status",
   "title": "A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis",
   "sponsor": "Janssen Research & Development, LLC",
   "phase": "P3",
   "pcd": "2028-01-14",
   "what": [
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 882 \u2192 896"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07196748",
   "registry": "https://clinicaltrials.gov/study/NCT07196748"
  },
  {
   "id": "NCT07837115",
   "kind": "status",
   "title": "A Study to Assess the Relative Bioavailability of Irafamdastat (BMS-986368) and to Assess the Food Effect on the Pharmacokinetics of Irafamdastat in Healthy Adu",
   "sponsor": "Celgene",
   "phase": "P1",
   "pcd": "2026-12-19",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07837115",
   "registry": "https://clinicaltrials.gov/study/NCT07837115"
  },
  {
   "id": "NCT06617429",
   "kind": "status",
   "title": "Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)",
   "sponsor": "Ultragenyx Pharmaceutical Inc",
   "phase": "P3",
   "pcd": "2026-07-10",
   "what": [
    "status: ACTIVE_NOT_RECRUITING \u2192 TERMINATED",
    "why stopped:  \u2192 Lack of efficacy"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06617429",
   "registry": "https://clinicaltrials.gov/study/NCT06617429"
  },
  {
   "id": "NCT07913009",
   "kind": "new",
   "title": "Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Hepatic Impairment",
   "sponsor": "Haisco Pharmaceutical Group Co., Ltd.",
   "phase": "P1",
   "pcd": "2026-12",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913009",
   "registry": "https://clinicaltrials.gov/study/NCT07913009"
  },
  {
   "id": "NCT07911800",
   "kind": "new",
   "title": "Phase 3 Study of rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures.",
   "sponsor": "MIBIO PTE. LTD.",
   "phase": "P3",
   "pcd": "2028-10-31",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07911800",
   "registry": "https://clinicaltrials.gov/study/NCT07911800"
  },
  {
   "id": "NCT02612454",
   "kind": "firmed",
   "title": "Study to Assess the Long-term Safety of Dupilumab Administered in Participants \u22656 Months to <18 Years of Age With Atopic Dermatitis (AD)",
   "sponsor": "Regeneron Pharmaceuticals",
   "phase": "P3",
   "pcd": "2026-10-09",
   "what": [
    "primary completion: 2026-10-07 \u2192 2026-10-09",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT02612454",
   "registry": "https://clinicaltrials.gov/study/NCT02612454"
  },
  {
   "id": "NCT07108283",
   "kind": "status",
   "title": "A Study of Zasocitinib in Adults With Nonsegmental Vitiligo",
   "sponsor": "Takeda",
   "phase": "P2",
   "pcd": "2027-03-26",
   "what": [
    "primary completion: 2027-10-12 \u2192 2027-03-26",
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 200 \u2192 207"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07108283",
   "registry": "https://clinicaltrials.gov/study/NCT07108283"
  },
  {
   "id": "NCT07909837",
   "kind": "new",
   "title": "A Phase 1 Clinical Trial of NTQ6179 Tablets in Healthy Volunteers",
   "sponsor": "Nanjing Chia-tai Tianqing Pharmaceutical",
   "phase": "P1",
   "pcd": "2027-04",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07909837",
   "registry": "https://clinicaltrials.gov/study/NCT07909837"
  },
  {
   "id": "NCT07914348",
   "kind": "new",
   "title": "Evaluation of LB-208 (HTR1B Antagonist) in Adult Patients With Relapsed or Refractory Solid Tumours and Lymphoma",
   "sponsor": "Leukos Biotech S.L.",
   "phase": "P1",
   "pcd": "2026-12",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07914348",
   "registry": "https://clinicaltrials.gov/study/NCT07914348"
  },
  {
   "id": "NCT07276789",
   "kind": "slipped",
   "title": "Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non S",
   "sponsor": "Integro Theranostics",
   "phase": "P2",
   "pcd": "2027-06",
   "what": [
    "primary completion: 2026-08 \u2192 2027-06",
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07276789",
   "registry": "https://clinicaltrials.gov/study/NCT07276789"
  },
  {
   "id": "NCT06961344",
   "kind": "changed",
   "title": "An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)",
   "sponsor": "Tisento Therapeutics",
   "phase": "P2",
   "pcd": "2026-10-26",
   "what": [
    "why stopped: On 5 October 2026 the study was terminated based on results from the parent study, which did not meet its primary or secondary efficacy endpoints. The decision was not related to a safety. \u2192 Terminated based on results from the parent study, which did not meet its primary or secondary efficacy endpoints. The decision was not related to a safety."
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06961344",
   "registry": "https://clinicaltrials.gov/study/NCT06961344"
  },
  {
   "id": "NCT07321873",
   "kind": "status",
   "title": "A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis",
   "sponsor": "Janssen Research & Development, LLC",
   "phase": "P2",
   "pcd": "2027-06-28",
   "what": [
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 240 \u2192 157"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07321873",
   "registry": "https://clinicaltrials.gov/study/NCT07321873"
  },
  {
   "id": "NCT07912996",
   "kind": "new",
   "title": "Study to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital Herpes",
   "sponsor": "Gilead Sciences",
   "phase": "P2",
   "pcd": "2027-11",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07912996",
   "registry": "https://clinicaltrials.gov/study/NCT07912996"
  },
  {
   "id": "NCT05676242",
   "kind": "new",
   "title": "A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis",
   "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
   "phase": "P3",
   "pcd": "2026-03-12",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT05676242",
   "registry": "https://clinicaltrials.gov/study/NCT05676242"
  },
  {
   "id": "NCT07912840",
   "kind": "new",
   "title": "Bioequivalence Study Between YHP2508B and YHR2602 in Healthy Subjects",
   "sponsor": "Yuhan Corporation",
   "phase": "P1",
   "pcd": "2027-01-26",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07912840",
   "registry": "https://clinicaltrials.gov/study/NCT07912840"
  },
  {
   "id": "NCT07914088",
   "kind": "new",
   "title": "A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis",
   "sponsor": "Arjil Pharmaceuticals LLC",
   "phase": "P2",
   "pcd": "2027-12-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07914088",
   "registry": "https://clinicaltrials.gov/study/NCT07914088"
  },
  {
   "id": "NCT06415344",
   "kind": "new",
   "title": "Long-term Extension of GTX-102 in Angelman Syndrome",
   "sponsor": "Ultragenyx Pharmaceutical Inc",
   "phase": "P3",
   "pcd": "2026-10-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06415344",
   "registry": "https://clinicaltrials.gov/study/NCT06415344"
  },
  {
   "id": "NCT04716452",
   "kind": "slipped",
   "title": "Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia",
   "sponsor": "Keystone Nano, Inc",
   "phase": "P1",
   "pcd": "2027-01-30",
   "what": [
    "primary completion: 2026-09-30 \u2192 2027-01-30"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT04716452",
   "registry": "https://clinicaltrials.gov/study/NCT04716452"
  },
  {
   "id": "NCT05517980",
   "kind": "slipped",
   "title": "Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis",
   "sponsor": "Kira Pharmacenticals (US), LLC.",
   "phase": "P2",
   "pcd": "2028-12",
   "what": [
    "primary completion: 2026-03 \u2192 2028-12",
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT05517980",
   "registry": "https://clinicaltrials.gov/study/NCT05517980"
  },
  {
   "id": "NCT05270525",
   "kind": "changed",
   "title": "Effect of Ensifentrine (MK-5884/RPL554) on Sputum Markers of Inflammation in Chronic Obstructive Pulmonary Disease (COPD) (MK-5884-023/RPL554-CO-207)",
   "sponsor": "Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA",
   "phase": "P2",
   "pcd": "2027-03-01",
   "what": [
    "enrollment: 56 \u2192 70",
    "primary outcome text: The change from baseline in sputum neutrophils at Week 8 (absolute change in cell numbers) \u2192 The Absolute Change From Baseline in Sputum Neutrophil Cell Numbers"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT05270525",
   "registry": "https://clinicaltrials.gov/study/NCT05270525"
  },
  {
   "id": "NCT06397131",
   "kind": "status",
   "title": "A Study to Determine the Safety and Efficacy of NT-501 With M-CHFM",
   "sponsor": "Neurotech Pharmaceuticals",
   "phase": "P3",
   "pcd": "2028-05-01",
   "what": [
    "status: ACTIVE_NOT_RECRUITING \u2192 RECRUITING",
    "enrollment: 12 \u2192 60",
    "primary outcome text: Rate of Change in Ellipsoid Zone (EZ) Area Loss \u2192 Cohort 1 (Extension) - Efficacy"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06397131",
   "registry": "https://clinicaltrials.gov/study/NCT06397131"
  },
  {
   "id": "NCT07452692",
   "kind": "firmed",
   "title": "A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects",
   "sponsor": "Corium Innovations, Inc.",
   "phase": "P1",
   "pcd": "2026-09-26",
   "what": [
    "primary completion: 2026-10-06 \u2192 2026-09-26",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07452692",
   "registry": "https://clinicaltrials.gov/study/NCT07452692"
  },
  {
   "id": "NCT07908654",
   "kind": "new",
   "title": "A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older",
   "sponsor": "Guangzhou Patronus Biotech Co., Ltd.",
   "phase": "P3",
   "pcd": "2027-09",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07908654",
   "registry": "https://clinicaltrials.gov/study/NCT07908654"
  },
  {
   "id": "NCT07244263",
   "kind": "status",
   "title": "A Study of Zasocitinib in Adults With Hidradenitis Suppurativa",
   "sponsor": "Takeda",
   "phase": "P2",
   "pcd": "2028-02-22",
   "what": [
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07244263",
   "registry": "https://clinicaltrials.gov/study/NCT07244263"
  },
  {
   "id": "NCT06807424",
   "kind": "status",
   "title": "A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthriti",
   "sponsor": "Janssen Research & Development, LLC",
   "phase": "P3",
   "pcd": "2027-02-10",
   "what": [
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 750 \u2192 813"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06807424",
   "registry": "https://clinicaltrials.gov/study/NCT06807424"
  },
  {
   "id": "NCT07912268",
   "kind": "new",
   "title": "Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
   "sponsor": "Jiangsu Simcere Pharmaceutical Co., Ltd.",
   "phase": "P1",
   "pcd": "2028-12-01",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07912268",
   "registry": "https://clinicaltrials.gov/study/NCT07912268"
  },
  {
   "id": "NCT06980948",
   "kind": "status",
   "title": "Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN)",
   "sponsor": "Sangamo Therapeutics",
   "phase": "P1/P2",
   "pcd": "2027-07",
   "what": [
    "status: RECRUITING \u2192 SUSPENDED",
    "why stopped:  \u2192 Study is suspended while Sangamo seeks a new sponsor for the ST-503-101 study"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06980948",
   "registry": "https://clinicaltrials.gov/study/NCT06980948"
  },
  {
   "id": "NCT07911982",
   "kind": "new",
   "title": "Safety, Tolerability and Pharmacokinetics of ICP-B161 in Healthy Adults Volunteers",
   "sponsor": "Beijing InnoCare Pharma Tech Co., Ltd.",
   "phase": "P1",
   "pcd": "2028-03",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07911982",
   "registry": "https://clinicaltrials.gov/study/NCT07911982"
  },
  {
   "id": "NCT07914231",
   "kind": "new",
   "title": "A Study to Assess the Safety and Effectiveness of COL-5671-PRO Capsules in Adults With Moderate-to-Severe Plaque Psoriasis",
   "sponsor": "Coultreon Biopharma",
   "phase": "P2",
   "pcd": "2027-09-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07914231",
   "registry": "https://clinicaltrials.gov/study/NCT07914231"
  },
  {
   "id": "NCT06862453",
   "kind": "slipped",
   "title": "Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Na\u00efve Adults",
   "sponsor": "Sanaria Inc.",
   "phase": "P1",
   "pcd": "2027-08-30",
   "what": [
    "primary completion: 2026-09-30 \u2192 2027-08-30",
    "enrollment: 58 \u2192 42"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06862453",
   "registry": "https://clinicaltrials.gov/study/NCT06862453"
  },
  {
   "id": "NCT07913074",
   "kind": "new",
   "title": "A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pr",
   "sponsor": "Tavo Biotherapeutics",
   "phase": "P2",
   "pcd": "2027-06-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913074",
   "registry": "https://clinicaltrials.gov/study/NCT07913074"
  },
  {
   "id": "NCT07914660",
   "kind": "new",
   "title": "Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)",
   "sponsor": "Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.",
   "phase": "P2",
   "pcd": "2028-12-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07914660",
   "registry": "https://clinicaltrials.gov/study/NCT07914660"
  },
  {
   "id": "NCT07021547",
   "kind": "firmed",
   "title": "A Study of LY3867070 in Healthy Participants",
   "sponsor": "Eli Lilly and Company",
   "phase": "P1",
   "pcd": "2026-09-30",
   "what": [
    "primary completion: 2026-10 \u2192 2026-09-30",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED",
    "enrollment: 196 \u2192 141"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07021547",
   "registry": "https://clinicaltrials.gov/study/NCT07021547"
  },
  {
   "id": "NCT07913048",
   "kind": "new",
   "title": "A Study to Evaluate the PK/PD and Safety of KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants",
   "sponsor": "Hunan Kelun Pharmaceutical Co., Ltd.",
   "phase": "P1",
   "pcd": "2026-11-24",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07913048",
   "registry": "https://clinicaltrials.gov/study/NCT07913048"
  },
  {
   "id": "NCT06374485",
   "kind": "new",
   "title": "Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment",
   "sponsor": "Lee's Pharmaceutical Limited",
   "phase": "P1",
   "pcd": "2026-08-17",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06374485",
   "registry": "https://clinicaltrials.gov/study/NCT06374485"
  },
  {
   "id": "NCT06459869",
   "kind": "firmed",
   "title": "NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer",
   "sponsor": "Akamis Bio",
   "phase": "P1",
   "pcd": "2027-01-30",
   "what": [
    "primary completion: 2026-12-30 \u2192 2027-01-30",
    "enrollment: 30 \u2192 33"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06459869",
   "registry": "https://clinicaltrials.gov/study/NCT06459869"
  },
  {
   "id": "NCT07221292",
   "kind": "slipped",
   "title": "Pivotal Study of N-acetyl-L-leucine for CACNA1A",
   "sponsor": "IntraBio Inc",
   "phase": "P3",
   "pcd": "2028-05-01",
   "what": [
    "primary completion: 2027-05-01 \u2192 2028-05-01",
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING"
   ],
   "date": "2026-11-03",
   "url": "https://saros.gcarosso.bio/#t=NCT07221292",
   "registry": "https://clinicaltrials.gov/study/NCT07221292"
  },
  {
   "id": "NCT06317311",
   "kind": "slipped",
   "title": "A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer",
   "sponsor": "GlaxoSmithKline",
   "phase": "P2",
   "pcd": "2026-12-14",
   "what": [
    "primary completion: 2026-07-15 \u2192 2026-12-14"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06317311",
   "registry": "https://clinicaltrials.gov/study/NCT06317311"
  },
  {
   "id": "NCT06745336",
   "kind": "slipped",
   "title": "Clinical Study of CS-001 as a Treatment for Canities (Grey Hair)",
   "sponsor": "Applied Biology, Inc.",
   "phase": "P3",
   "pcd": "2027-12-15",
   "what": [
    "primary completion: 2027-06-15 \u2192 2027-12-15"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06745336",
   "registry": "https://clinicaltrials.gov/study/NCT06745336"
  },
  {
   "id": "NCT07696962",
   "kind": "slipped",
   "title": "Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease",
   "sponsor": "Xeno Holdings (US), LLC dba ChoironeX",
   "phase": "P1",
   "pcd": "2028-06-30",
   "what": [
    "primary completion: 2028-05-30 \u2192 2028-06-30",
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07696962",
   "registry": "https://clinicaltrials.gov/study/NCT07696962"
  },
  {
   "id": "NCT07412288",
   "kind": "firmed",
   "title": "First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants",
   "sponsor": "Kymera Therapeutics, Inc.",
   "phase": "P1",
   "pcd": "2026-08-22",
   "what": [
    "primary completion: 2026-12 \u2192 2026-08-22",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07412288",
   "registry": "https://clinicaltrials.gov/study/NCT07412288"
  },
  {
   "id": "NCT07667569",
   "kind": "firmed",
   "title": "A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental Vitiligo",
   "sponsor": "Idorsia Pharmaceuticals Ltd.",
   "phase": "P2",
   "pcd": "2027-06-28",
   "what": [
    "primary completion: 2027-06 \u2192 2027-06-28",
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07667569",
   "registry": "https://clinicaltrials.gov/study/NCT07667569"
  },
  {
   "id": "NCT07697625",
   "kind": "firmed",
   "title": "A Clinical Trial of MK-4082 in Healthy Participants (MK-4082-005)",
   "sponsor": "Merck Sharp & Dohme LLC",
   "phase": "P1",
   "pcd": "2026-10-06",
   "what": [
    "primary completion: 2026-09-28 \u2192 2026-10-06",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07697625",
   "registry": "https://clinicaltrials.gov/study/NCT07697625"
  },
  {
   "id": "NCT07160608",
   "kind": "status",
   "title": "Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis",
   "sponsor": "Alexion Pharmaceuticals, Inc.",
   "phase": "P2",
   "pcd": "2027-10-11",
   "what": [
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 75 \u2192 78"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07160608",
   "registry": "https://clinicaltrials.gov/study/NCT07160608"
  },
  {
   "id": "NCT07766499",
   "kind": "status",
   "title": "A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)",
   "sponsor": "Calixis Inc.",
   "phase": "P2",
   "pcd": "2027-12-31",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07766499",
   "registry": "https://clinicaltrials.gov/study/NCT07766499"
  },
  {
   "id": "NCT07910630",
   "kind": "new",
   "title": "A Phase II Study Evaluating the Efficacy and Safety of Recombinant Human Truncated Plasmin Injection (JZB32) in Patients With Vitreomacular Traction",
   "sponsor": "Jiangsu Jingze Biopharmaceutical Co., Ltd.",
   "phase": "P2",
   "pcd": "2027-12-28",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07910630",
   "registry": "https://clinicaltrials.gov/study/NCT07910630"
  },
  {
   "id": "NCT07909655",
   "kind": "new",
   "title": "A Phase 2 Study of HB0056 in Patients With Idiopathic Pulmonary Fibrosis",
   "sponsor": "Shanghai Huaota Biopharmaceutical Co., Ltd.",
   "phase": "P2",
   "pcd": "2028-01",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07909655",
   "registry": "https://clinicaltrials.gov/study/NCT07909655"
  },
  {
   "id": "NCT06762548",
   "kind": "slipped",
   "title": "Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia",
   "sponsor": "Applied Biology, Inc.",
   "phase": "P3",
   "pcd": "2028-03-11",
   "what": [
    "primary completion: 2026-09-11 \u2192 2028-03-11"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06762548",
   "registry": "https://clinicaltrials.gov/study/NCT06762548"
  },
  {
   "id": "NCT07756580",
   "kind": "status",
   "title": "A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines",
   "sponsor": "AbbVie",
   "phase": "P1",
   "pcd": "2027-02",
   "what": [
    "primary completion: 2027-03 \u2192 2027-02",
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 120 \u2192 143"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07756580",
   "registry": "https://clinicaltrials.gov/study/NCT07756580"
  },
  {
   "id": "NCT04849728",
   "kind": "firmed",
   "title": "A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 an",
   "sponsor": "Inventiva Pharma",
   "phase": "P3",
   "pcd": "2026-09-29",
   "what": [
    "primary completion: 2027-09-30 \u2192 2026-09-29",
    "date type: ESTIMATED \u2192 ACTUAL"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT04849728",
   "registry": "https://clinicaltrials.gov/study/NCT04849728"
  },
  {
   "id": "NCT07754123",
   "kind": "status",
   "title": "Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLC",
   "sponsor": "Jiangsu Hansoh Pharmaceutical Co., Ltd.",
   "phase": "P3",
   "pcd": "2028-08-31",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07754123",
   "registry": "https://clinicaltrials.gov/study/NCT07754123"
  },
  {
   "id": "NCT07909070",
   "kind": "new",
   "title": "A Study to Investigate the Pharmacokinetics of JMKX003142 in Healthy Participants and Participants With Hepatic Impairment",
   "sponsor": "Jemincare",
   "phase": "P1",
   "pcd": "2027-05-30",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07909070",
   "registry": "https://clinicaltrials.gov/study/NCT07909070"
  },
  {
   "id": "NCT04898543",
   "kind": "firmed",
   "title": "QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors",
   "sponsor": "ImmunityBio, Inc.",
   "phase": "P1",
   "pcd": "2026-02-02",
   "what": [
    "primary completion: 2026-05-31 \u2192 2026-02-02",
    "date type: ESTIMATED \u2192 ACTUAL"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT04898543",
   "registry": "https://clinicaltrials.gov/study/NCT04898543"
  },
  {
   "id": "NCT07908641",
   "kind": "new",
   "title": "Comparing the Extent to Which Apremilast is Made Available in the Body After Administration as an Extended-release or Immediate-release Formulation",
   "sponsor": "Amgen",
   "phase": "P1",
   "pcd": "2027-01-10",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07908641",
   "registry": "https://clinicaltrials.gov/study/NCT07908641"
  },
  {
   "id": "NCT07829653",
   "kind": "status",
   "title": "A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through Menopause",
   "sponsor": "Astellas Pharma Inc",
   "phase": "P3",
   "pcd": "2028-03-31",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07829653",
   "registry": "https://clinicaltrials.gov/study/NCT07829653"
  },
  {
   "id": "NCT07323095",
   "kind": "status",
   "title": "Evaluate the Efficacy and Safety of ABP-671 in Subjects With Chronic Kidney Disease and Hyperuricaemia",
   "sponsor": "Atom Therapeutics Co., Ltd",
   "phase": "P2",
   "pcd": "2027-10-31",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07323095",
   "registry": "https://clinicaltrials.gov/study/NCT07323095"
  },
  {
   "id": "NCT03737214",
   "kind": "new",
   "title": "A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease",
   "sponsor": "Idorsia Pharmaceuticals Ltd.",
   "phase": "P3",
   "pcd": "2026-08-31",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT03737214",
   "registry": "https://clinicaltrials.gov/study/NCT03737214"
  },
  {
   "id": "NCT06249919",
   "kind": "firmed",
   "title": "A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients",
   "sponsor": "Neuracle Science Co., LTD.",
   "phase": "P1/P2",
   "pcd": "2026-05-04",
   "what": [
    "primary completion: 2026-05-31 \u2192 2026-05-04",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED",
    "enrollment: 138 \u2192 113"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06249919",
   "registry": "https://clinicaltrials.gov/study/NCT06249919"
  },
  {
   "id": "NCT07367971",
   "kind": "firmed",
   "title": "Drug-Drug Interaction Study of ABP-671 in Gout Patients",
   "sponsor": "Atom Therapeutics Co., Ltd",
   "phase": "P1",
   "pcd": "2026-08-19",
   "what": [
    "primary completion: 2026-07-31 \u2192 2026-08-19",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED",
    "enrollment: 20 \u2192 22"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07367971",
   "registry": "https://clinicaltrials.gov/study/NCT07367971"
  },
  {
   "id": "NCT07909031",
   "kind": "new",
   "title": "CR-002 in Adult Participants With Locally Advanced or Metastatic Solid Tumors",
   "sponsor": "Crescent Biopharma, Inc.",
   "phase": "P1/P2",
   "pcd": "2028-10",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07909031",
   "registry": "https://clinicaltrials.gov/study/NCT07909031"
  },
  {
   "id": "NCT06924320",
   "kind": "firmed",
   "title": "A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes",
   "sponsor": "Pfizer",
   "phase": "P1/P2",
   "pcd": "2026-09-29",
   "what": [
    "primary completion: 2026-09-15 \u2192 2026-09-29",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 COMPLETED",
    "enrollment: 381 \u2192 201"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06924320",
   "registry": "https://clinicaltrials.gov/study/NCT06924320"
  },
  {
   "id": "NCT05852691",
   "kind": "firmed",
   "title": "A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced",
   "sponsor": "Hoffmann-La Roche",
   "phase": "P2",
   "pcd": "2026-10-15",
   "what": [
    "primary completion: 2026-10-19 \u2192 2026-10-15",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT05852691",
   "registry": "https://clinicaltrials.gov/study/NCT05852691"
  },
  {
   "id": "NCT06008093",
   "kind": "changed",
   "title": "A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherap",
   "sponsor": "AstraZeneca",
   "phase": "P2",
   "pcd": "2026-10-27",
   "what": [
    "primary completion: 2026-10-23 \u2192 2026-10-27"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06008093",
   "registry": "https://clinicaltrials.gov/study/NCT06008093"
  },
  {
   "id": "NCT06748625",
   "kind": "status",
   "title": "Efficacy of a Multidomain Intervention on Lifestyle Risk Factors for Dementia Prevention",
   "sponsor": "LuciLab",
   "phase": "P3",
   "pcd": "2026-03-23",
   "what": [
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED",
    "enrollment: 370 \u2192 368"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06748625",
   "registry": "https://clinicaltrials.gov/study/NCT06748625"
  },
  {
   "id": "NCT07123454",
   "kind": "slipped",
   "title": "A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma",
   "sponsor": "AstraZeneca",
   "phase": "P1/P2",
   "pcd": "2028-07-04",
   "what": [
    "primary completion: 2028-03-01 \u2192 2028-07-04",
    "enrollment: 91 \u2192 164",
    "primary outcome text: Percentage of participants with dose-limiting toxicities (DLTs) \u2192 Percentage of participants with dose-limiting toxicities (DLTs) during the DLT period"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07123454",
   "registry": "https://clinicaltrials.gov/study/NCT07123454"
  },
  {
   "id": "NCT06891417",
   "kind": "changed",
   "title": "Phase 1 Study of Chlamydia Trachomatis mRNA Vaccine in Adults.",
   "sponsor": "Sanofi",
   "phase": "P1",
   "pcd": "2027-11-03",
   "what": [
    "primary completion: 2028-01-03 \u2192 2027-11-03",
    "enrollment: 1560 \u2192 80"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06891417",
   "registry": "https://clinicaltrials.gov/study/NCT06891417"
  },
  {
   "id": "NCT07911514",
   "kind": "new",
   "title": "A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234",
   "sponsor": "AstraZeneca",
   "phase": "P1",
   "pcd": "2027-05-04",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07911514",
   "registry": "https://clinicaltrials.gov/study/NCT07911514"
  },
  {
   "id": "NCT03533283",
   "kind": "firmed",
   "title": "An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma",
   "sponsor": "Hoffmann-La Roche",
   "phase": "P1/P2",
   "pcd": "2026-10-22",
   "what": [
    "primary completion: 2026-10-16 \u2192 2026-10-22",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT03533283",
   "registry": "https://clinicaltrials.gov/study/NCT03533283"
  },
  {
   "id": "NCT06980428",
   "kind": "changed",
   "title": "A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotei",
   "sponsor": "AstraZeneca",
   "phase": "P1",
   "pcd": "2027-04-09",
   "what": [
    "enrollment: 136 \u2192 171"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06980428",
   "registry": "https://clinicaltrials.gov/study/NCT06980428"
  },
  {
   "id": "NCT05405595",
   "kind": "slipped",
   "title": "ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors",
   "sponsor": "Adagene Inc",
   "phase": "P1/P2",
   "pcd": "2027-06-30",
   "what": [
    "primary completion: 2026-10-31 \u2192 2027-06-30"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT05405595",
   "registry": "https://clinicaltrials.gov/study/NCT05405595"
  },
  {
   "id": "NCT07562152",
   "kind": "changed",
   "title": "Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma",
   "sponsor": "Immuneering Corporation",
   "phase": "P3",
   "pcd": "2028-06",
   "what": [
    "enrollment: 510 \u2192 570"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07562152",
   "registry": "https://clinicaltrials.gov/study/NCT07562152"
  },
  {
   "id": "NCT06209736",
   "kind": "firmed",
   "title": "Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN",
   "sponsor": "Omeros Corporation",
   "phase": "P2",
   "pcd": "2026-04-14",
   "what": [
    "primary completion: 2026-01 \u2192 2026-04-14",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: RECRUITING \u2192 TERMINATED",
    "enrollment: 20 \u2192 3",
    "why stopped:  \u2192 The study was terminated for strategic reasons related to the molecule's recent acquisition"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06209736",
   "registry": "https://clinicaltrials.gov/study/NCT06209736"
  },
  {
   "id": "NCT07166354",
   "kind": "slipped",
   "title": "Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)",
   "sponsor": "Applied Biology, Inc.",
   "phase": "P1/P2",
   "pcd": "2027-10-15",
   "what": [
    "primary completion: 2027-06-15 \u2192 2027-10-15"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07166354",
   "registry": "https://clinicaltrials.gov/study/NCT07166354"
  },
  {
   "id": "NCT07911293",
   "kind": "new",
   "title": "Intratumoral Chlorine Dioxide Injection in Advanced Solid Tumors",
   "sponsor": "SunGlow Innovations LLC",
   "phase": "P1",
   "pcd": "2028-03",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07911293",
   "registry": "https://clinicaltrials.gov/study/NCT07911293"
  },
  {
   "id": "NCT07260877",
   "kind": "status",
   "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult ",
   "sponsor": "Ventus Therapeutics U.S., Inc.",
   "phase": "P2",
   "pcd": "2026-12",
   "what": [
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07260877",
   "registry": "https://clinicaltrials.gov/study/NCT07260877"
  },
  {
   "id": "NCT07908316",
   "kind": "new",
   "title": "Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Gluca",
   "sponsor": "Amgen",
   "phase": "P1",
   "pcd": "2027-12-20",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07908316",
   "registry": "https://clinicaltrials.gov/study/NCT07908316"
  },
  {
   "id": "NCT06268886",
   "kind": "changed",
   "title": "Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease",
   "sponsor": "Bristol-Myers Squibb",
   "phase": "P2",
   "pcd": "2026-12-17",
   "what": [
    "primary completion: 2027-03-18 \u2192 2026-12-17"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06268886",
   "registry": "https://clinicaltrials.gov/study/NCT06268886"
  },
  {
   "id": "NCT07492680",
   "kind": "changed",
   "title": "A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozyg",
   "sponsor": "Bristol-Myers Squibb",
   "phase": "P2",
   "pcd": "2028-08-15",
   "what": [
    "enrollment: 260 \u2192 254"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07492680",
   "registry": "https://clinicaltrials.gov/study/NCT07492680"
  },
  {
   "id": "NCT06505824",
   "kind": "slipped",
   "title": "A Study of BL-M14D1 in Patients With Locally Advanced or Metastatic Small Cell Lung Cancer, Neuroendocrine Tumors and Other Solid Tumors",
   "sponsor": "Biokin (Shanghai) Biopharmaceutical Co., Ltd.",
   "phase": "P1",
   "pcd": "2027-06",
   "what": [
    "primary completion: 2026-08 \u2192 2027-06",
    "enrollment: 22 \u2192 115"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06505824",
   "registry": "https://clinicaltrials.gov/study/NCT06505824"
  },
  {
   "id": "NCT07840729",
   "kind": "status",
   "title": "Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants",
   "sponsor": "Shanghai JMT-Bio Inc.",
   "phase": "P1",
   "pcd": "2027-02-28",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07840729",
   "registry": "https://clinicaltrials.gov/study/NCT07840729"
  },
  {
   "id": "NCT06797297",
   "kind": "slipped",
   "title": "A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal",
   "sponsor": "Innovent Biologics (Suzhou) Co. Ltd.",
   "phase": "P2",
   "pcd": "2026-12-31",
   "what": [
    "primary completion: 2026-03-31 \u2192 2026-12-31",
    "status: RECRUITING \u2192 ACTIVE_NOT_RECRUITING",
    "enrollment: 180 \u2192 203"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06797297",
   "registry": "https://clinicaltrials.gov/study/NCT06797297"
  },
  {
   "id": "NCT06054113",
   "kind": "changed",
   "title": "Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)",
   "sponsor": "Amgen",
   "phase": "P2",
   "pcd": "2026-01-06",
   "what": [
    "primary completion: 2026-01-05 \u2192 2026-01-06"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06054113",
   "registry": "https://clinicaltrials.gov/study/NCT06054113"
  },
  {
   "id": "NCT07357675",
   "kind": "slipped",
   "title": "A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass",
   "sponsor": "EBI Anti Sepsis BV",
   "phase": "P3",
   "pcd": "2027-10-01",
   "what": [
    "primary completion: 2027-06-01 \u2192 2027-10-01",
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07357675",
   "registry": "https://clinicaltrials.gov/study/NCT07357675"
  },
  {
   "id": "NCT07354477",
   "kind": "firmed",
   "title": "Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation",
   "sponsor": "Qlaris Bio, Inc.",
   "phase": "P2",
   "pcd": "2026-10-01",
   "what": [
    "primary completion: 2026-10 \u2192 2026-10-01",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 COMPLETED",
    "enrollment: 14 \u2192 9"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07354477",
   "registry": "https://clinicaltrials.gov/study/NCT07354477"
  },
  {
   "id": "NCT07909291",
   "kind": "new",
   "title": "A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 2 Study to Evaluate the Safety and Efficacy of Two Dosage Regimens of a Novel Hydrocortisone Ace",
   "sponsor": "Cristcot LLC",
   "phase": "P2",
   "pcd": "2027-01",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07909291",
   "registry": "https://clinicaltrials.gov/study/NCT07909291"
  },
  {
   "id": "NCT07809906",
   "kind": "status",
   "title": "Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression",
   "sponsor": "Orum Therapeutics USA, Inc.",
   "phase": "P1",
   "pcd": "2028-12",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 RECRUITING"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07809906",
   "registry": "https://clinicaltrials.gov/study/NCT07809906"
  },
  {
   "id": "NCT06349811",
   "kind": "slipped",
   "title": "A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors",
   "sponsor": "Biokin (Shanghai) Biopharmaceutical Co., Ltd.",
   "phase": "P1",
   "pcd": "2027-06",
   "what": [
    "primary completion: 2026-05 \u2192 2027-06"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06349811",
   "registry": "https://clinicaltrials.gov/study/NCT06349811"
  },
  {
   "id": "NCT06501924",
   "kind": "new",
   "title": "Clinical Study of DA-002 and DA-005 as a Treatment for Hair Loss",
   "sponsor": "Applied Biology, Inc.",
   "phase": "P3",
   "pcd": "2027-10-17",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06501924",
   "registry": "https://clinicaltrials.gov/study/NCT06501924"
  },
  {
   "id": "NCT07908680",
   "kind": "new",
   "title": "A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia",
   "sponsor": "Novartis Pharmaceuticals",
   "phase": "P1",
   "pcd": "2028-03-06",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07908680",
   "registry": "https://clinicaltrials.gov/study/NCT07908680"
  },
  {
   "id": "NCT06985147",
   "kind": "slipped",
   "title": "A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)",
   "sponsor": "Disc Medicine, Inc",
   "phase": "P2",
   "pcd": "2027-07",
   "what": [
    "primary completion: 2027-02 \u2192 2027-07"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06985147",
   "registry": "https://clinicaltrials.gov/study/NCT06985147"
  },
  {
   "id": "NCT07073820",
   "kind": "firmed",
   "title": "A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Stu",
   "sponsor": "Pfizer",
   "phase": "P2",
   "pcd": "2026-10-09",
   "what": [
    "primary completion: 2028-08-24 \u2192 2026-10-09",
    "date type: ESTIMATED \u2192 ACTUAL",
    "status: ACTIVE_NOT_RECRUITING \u2192 TERMINATED",
    "why stopped:  \u2192 The study terminated due to a business decision and was not based on any safety and/or efficacy concerns."
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07073820",
   "registry": "https://clinicaltrials.gov/study/NCT07073820"
  },
  {
   "id": "NCT05607550",
   "kind": "new",
   "title": "Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal",
   "sponsor": "ArriVent BioPharma, Inc.",
   "phase": "P3",
   "pcd": "2026-10-06",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT05607550",
   "registry": "https://clinicaltrials.gov/study/NCT05607550"
  },
  {
   "id": "NCT07217301",
   "kind": "changed",
   "title": "A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer",
   "sponsor": "Takeda",
   "phase": "P3",
   "pcd": "2028-11-01",
   "what": [
    "enrollment: 600 \u2192 1200",
    "primary outcome text: Global Part: Confirmed Objective Response Rate (cORR) as Assessed by Blinded Independent Central Review (BICR) per Response Evaluation Criteria in Solid Tumors  \u2192 Squamous NSCLC Part: Confirmed Objective Response Rate (cORR) as Assessed by Blinded Independent Central Review (BICR) per Response Evaluation Criteria in Solid"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07217301",
   "registry": "https://clinicaltrials.gov/study/NCT07217301"
  },
  {
   "id": "NCT07777211",
   "kind": "changed",
   "title": "A Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer",
   "sponsor": "Beijing Gene Key Life Technology Co., Ltd",
   "phase": "P1/P2",
   "pcd": "2027-03-31",
   "what": [
    "primary outcome text: Incidence of Dose-Limiting Toxicities \u2192 Phase I: Incidence of Dose-Limiting Toxicities"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT07777211",
   "registry": "https://clinicaltrials.gov/study/NCT07777211"
  },
  {
   "id": "NCT05170204",
   "kind": "new",
   "title": "A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung C",
   "sponsor": "Hoffmann-La Roche",
   "phase": "P3",
   "pcd": "2027-01-19",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT05170204",
   "registry": "https://clinicaltrials.gov/study/NCT05170204"
  },
  {
   "id": "NCT06280378",
   "kind": "new",
   "title": "\u03b2-Thalassemia Treatment With KL003 Cell Injection",
   "sponsor": "Kanglin Biotechnology (Hangzhou) Co., Ltd.",
   "phase": "P1/P2",
   "pcd": "2027-11-20",
   "what": [
    "new in the registry"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06280378",
   "registry": "https://clinicaltrials.gov/study/NCT06280378"
  },
  {
   "id": "NCT05687682",
   "kind": "slipped",
   "title": "Safety of AM-928 Infusion in Advanced Solid Tumors",
   "sponsor": "AcadeMab Biomedical Inc.",
   "phase": "P1",
   "pcd": "2027-06",
   "what": [
    "primary completion: 2026-06 \u2192 2027-06"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT05687682",
   "registry": "https://clinicaltrials.gov/study/NCT05687682"
  },
  {
   "id": "NCT06959706",
   "kind": "slipped",
   "title": "Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors",
   "sponsor": "Tagworks Pharmaceuticals BV",
   "phase": "P1",
   "pcd": "2027-10",
   "what": [
    "primary completion: 2026-09 \u2192 2027-10",
    "enrollment: 50 \u2192 90"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06959706",
   "registry": "https://clinicaltrials.gov/study/NCT06959706"
  },
  {
   "id": "NCT06245915",
   "kind": "slipped",
   "title": "AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)",
   "sponsor": "Arsenal Biosciences, Inc.",
   "phase": "P1/P2",
   "pcd": "2026-12-31",
   "what": [
    "primary completion: 2026-03-31 \u2192 2026-12-31"
   ],
   "date": "2026-11-02",
   "url": "https://saros.gcarosso.bio/#t=NCT06245915",
   "registry": "https://clinicaltrials.gov/study/NCT06245915"
  },
  {
   "id": "BBIO",
   "kind": "regulatory",
   "title": "Bridgebio Pharma, Inc. \u00b7 infigratinib \u00b7 2027-02-04",
   "sponsor": "Bridgebio Pharma, Inc.",
   "what": [
    "2027-05-08 \u2192 2027-02-04"
   ],
   "date": "2026-10-29",
   "url": "https://saros.gcarosso.bio/#tab=fda",
   "registry": "https://www.sec.gov/Archives/edgar/data/1743881/000174388126000033/bbio-20260930xex991.htm"
  },
  {
   "id": "CRMD",
   "kind": "regulatory",
   "title": "Cormedix Inc. \u00b7 pdufa \u00b7 2027-12-31",
   "sponsor": "Cormedix Inc.",
   "what": [
    "2027-03-31 \u2192 2027-12-31"
   ],
   "date": "2026-10-19",
   "url": "https://saros.gcarosso.bio/#tab=fda",
   "registry": "https://www.sec.gov/Archives/edgar/data/1410098/000121390026110477/ea030895701ex99-1.htm"
  },
  {
   "id": "AQST",
   "kind": "regulatory",
   "title": "Aquestive Therapeutics, Inc. \u00b7 Anaphylm \u00b7 2027-03-16",
   "sponsor": "Aquestive Therapeutics, Inc.",
   "what": [
    "2027-03-29 \u2192 2027-03-16"
   ],
   "date": "2026-10-15",
   "url": "https://saros.gcarosso.bio/#tab=fda",
   "registry": "https://www.sec.gov/Archives/edgar/data/1398733/000139873326000058/a2026-10x19aquestivepduf.htm"
  },
  {
   "id": "COGT",
   "kind": "regulatory",
   "title": "Cogent Biosciences, Inc. \u00b7 bezuclastinib \u00b7 2026-12-30",
   "sponsor": "Cogent Biosciences, Inc.",
   "what": [
    "2026-11-30 \u2192 2026-12-30"
   ],
   "date": "2026-08-10",
   "url": "https://saros.gcarosso.bio/#tab=fda",
   "registry": "https://www.sec.gov/Archives/edgar/data/1622229/000119312526341315/cogt-ex99_1.htm"
  },
  {
   "id": "NCT04648202",
   "kind": "status",
   "title": "FS120 Phase 1/1b Study in Patients With Advanced Malignancies",
   "sponsor": "invoX Pharma Limited",
   "phase": "P1",
   "pcd": "2026-03-01",
   "what": [
    "status: ACTIVE_NOT_RECRUITING \u2192 UNKNOWN"
   ],
   "date": "2025-06-27",
   "url": "https://saros.gcarosso.bio/#t=NCT04648202",
   "registry": "https://clinicaltrials.gov/study/NCT04648202"
  },
  {
   "id": "NCT06632613",
   "kind": "status",
   "title": "Efficacy and Safety of ENN0403 in Patients At High Risk for Acute Kidney Injury Following Elective Cardiac Surgery",
   "sponsor": "EnnovaBio",
   "phase": "P2",
   "pcd": "2026-02",
   "what": [
    "status: RECRUITING \u2192 UNKNOWN"
   ],
   "date": "2025-01-13",
   "url": "https://saros.gcarosso.bio/#t=NCT06632613",
   "registry": "https://clinicaltrials.gov/study/NCT06632613"
  },
  {
   "id": "NCT06474468",
   "kind": "status",
   "title": "A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer",
   "sponsor": "Shanghai Hengrui Pharmaceutical Co., Ltd.",
   "phase": "P1/P2",
   "pcd": "2026-10",
   "what": [
    "status: RECRUITING \u2192 UNKNOWN"
   ],
   "date": "2025-01-03",
   "url": "https://saros.gcarosso.bio/#t=NCT06474468",
   "registry": "https://clinicaltrials.gov/study/NCT06474468"
  },
  {
   "id": "NCT06637254",
   "kind": "status",
   "title": "A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma",
   "sponsor": "Haisco Pharmaceutical Group Co., Ltd.",
   "phase": "P2",
   "pcd": "2026-03-22",
   "what": [
    "status: ENROLLING_BY_INVITATION \u2192 UNKNOWN"
   ],
   "date": "2024-12-24",
   "url": "https://saros.gcarosso.bio/#t=NCT06637254",
   "registry": "https://clinicaltrials.gov/study/NCT06637254"
  },
  {
   "id": "NCT06558227",
   "kind": "status",
   "title": "Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma",
   "sponsor": "Suzhou Zelgen Biopharmaceuticals Co.,Ltd",
   "phase": "P2",
   "pcd": "2026-09",
   "what": [
    "status: RECRUITING \u2192 UNKNOWN"
   ],
   "date": "2024-12-16",
   "url": "https://saros.gcarosso.bio/#t=NCT06558227",
   "registry": "https://clinicaltrials.gov/study/NCT06558227"
  },
  {
   "id": "NCT06222879",
   "kind": "status",
   "title": "Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer",
   "sponsor": "Shandong Suncadia Medicine Co., Ltd.",
   "phase": "P1/P2",
   "pcd": "2026-10-31",
   "what": [
    "status: RECRUITING \u2192 UNKNOWN"
   ],
   "date": "2024-11-25",
   "url": "https://saros.gcarosso.bio/#t=NCT06222879",
   "registry": "https://clinicaltrials.gov/study/NCT06222879"
  },
  {
   "id": "NCT06649214",
   "kind": "status",
   "title": "A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia",
   "sponsor": "Qilu Pharmaceutical Co., Ltd.",
   "phase": "P3",
   "pcd": "2026-04",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 UNKNOWN"
   ],
   "date": "2024-10-21",
   "url": "https://saros.gcarosso.bio/#t=NCT06649214",
   "registry": "https://clinicaltrials.gov/study/NCT06649214"
  },
  {
   "id": "NCT06633783",
   "kind": "status",
   "title": "A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy\u00ae",
   "sponsor": "Hangzhou Jiuyuan Gene Engineering Co. Ltd.,",
   "phase": "P3",
   "pcd": "2026-05-30",
   "what": [
    "status: NOT_YET_RECRUITING \u2192 UNKNOWN"
   ],
   "date": "2024-10-09",
   "url": "https://saros.gcarosso.bio/#t=NCT06633783",
   "registry": "https://clinicaltrials.gov/study/NCT06633783"
  }
 ]
}